Skip to Content
Dixon Kaufman, MD, PhD, FACS

Contact Dr. Kaufman


(608) 265-6471

600 Highland Avenue
Madison, WI 53792

(608) 262-6280

Dixon Kaufman, MD, PhD, FACS

Ray D. Owen Professor of Surgery
Chairman, Division of Transplantation
Section of Kidney and Pancreas Surgery


  • MD, University of Minnesota, 1983
  • NIH National Research Service Award, 1986 – 1989
  • Surgery Internship and Residency, University of Minnesota, 1983 – 1991
  • Transplantation Fellowship, University of Minnesota, 1991 – 1992
  • PhD, University of Minnesota, 1994

Board Certifications

  • Fellow, American College of Surgeons, 1995
  • UNOS-Certified Primary Transplant Surgeon, Pancreas, 1993
  • Diplomate, American Board of Surgery, 1992

Professional Activities

Faculty Appointments:

  • Ray D. Owen Professor and Chief, Division of Transplantation, School of Medicine and Public Health, University of Wisconsin – Madision, 2011 – present
  • Director, Transplantation Service Line, University of Wisconsin Hospital and Clinics, Madison, WI, 2011 – present

Dr. Kaufman is involved with the following professional societies:

  • American Surgical Association
  • American Society of Transplant Surgeons
  • Association for Academic Surgery
  • Fellow, American College of Surgeons
  • Cell Transplant Society, Founding Member
  • Central Surgical Association
  • International Pancreas and Islet Association, Founding Member
  • Society of University Surgeons
  • The Surgical Biology Club I
  • Transplantation Society

Leadership Roles in Transplantation

Dr. Kaufman has held leadership positions in many facets of the transplant field. He has been very active with the American Society of Transplant Surgeons (ASTS) and has served as Chair of the Education Committee, the Executive Program Committee Chair for the American Transplant Congress, and on the Council of the ASTS. Dr. Kaufman is also very active with the United Network for Organ Sharing (UNOS). He was past Chair of the Pancreas/Islet Transplant Committee, served on the MPSC Committee and currently is Councilor of UNOS Region 7 and a member of the Executive Board. Dr. Kaufman is an associate editor for the American Journal of Transplantation, Transplantation Journal, and Clinical Transplantation Journal.

Clinical Specialties

Dr. Kaufman is certified by the American Board of Surgery in General Surgery. Dr Kaufman’s clinical focus has been on kidney, pancreas, and islet transplantation. He was the first pancreas transplant surgeon in North America to conduct and publish studies regarding steroid-free immunosuppression in pancreas transplantation, and the first to describe the use of alemtuzumab in pancreas transplants.

Research Interests

Dr. Kaufman’s experimental clinical research has focused on immunosuppression minimization in kidney transplant recipients, and human clinical trials of islet transplantation. His basic research efforts have focused on development of a tolerance induction protocol in large animals. It is supported by an NIH UO-1 award as part of the Non-human Primate Tolerance Study Group Consortium.

Active Clinical Trials
  • A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
    Principal Investigator(s): Dixon Kaufman, MD, PhD, FACS
    Status: Active, not recruiting
    [ NCT01780844]
    More Information
  • Islet Transplantation in Type 1 Diabetic Kidney Allograft Recipients: Efficacy of Islet After Kidney Transplantation (CIT-06)
    Principal Investigator(s): Dixon Kaufman, MD, PhD, FACS
    Status: Active, not recruiting
    [ NCT00468117]
    More Information
  • Randomized, Open Label, Multicenter Study of Belatacept-based Early Steroid Withdrawal Regimen With Alemtuzumab or rATG Induction Compared to Tacrolimus-based Early Steroid Withdrawal Regimen With rATG Induction in Renal Transplantation
    Principal Investigator(s): Dixon Kaufman, MD, PhD, FACS
    Status: Recruiting
    [ NCT01729494]
    More Information

Recent Publications
  • The Association Between Renin-Angiotensin System Blockade and Long-term Outcomes in Renal Transplant Recipients: The Wisconsin Allograft Recipient Database (WisARD).
    Shin JI, Palta M, Djamali A, Kaufman DB, Astor BC
    Transplantation 2015 Nov 12.
    [PubMed ID: 26566058]
    More Information
  • Predictors and outcomes of delayed graft function after living-donor kidney transplantation.
    Redfield RR, Scalea JR, Zens TJ, Muth B, Kaufman DB, Djamali A, Astor BC, Mohamed M
    Transpl. Int. 2015 Oct 3.
    [PubMed ID: 26432507]
    More Information
  • Older kidney transplant patients experience less antibody-mediated rejection: a retrospective study of patients with mild to moderate sensitization.
    Scalea JR, Redfield RR, Muth BL, Mohamed M, Wilson NA, Ellis TM, Kaufman DB, Djamali A
    Clin Transplant 2015 Sep 11.
    [PubMed ID: 26361077]
    More Information
  • When Do DCD Donors Die? Outcomes and Implications of DCD at a High-volume, Single-center OPO in the United States.
    Scalea JR, Redfield RR, Rizzari MD, Bennett R, Anderson ME, Anderson JE, Kaufman DB, Sollinger HW, Fernandez LA, Dʼalessandro AM, Mezrich J
    Ann. Surg. 2015 Jul 15.
    [PubMed ID: 26181480]
    More Information
  • C1q Binding Activity of De Novo Donor-specific HLA Antibodies in Renal Transplant Recipients With and Without Antibody-mediated Rejection.
    Yell M, Muth BL, Kaufman DB, Djamali A, Ellis TM
    Transplantation 2015 Jun; 99(6):1151-5.
    [PubMed ID: 25839705]
    More Information
  • Emergence of naturally occurring scaffolds for cell transplantation in type 1 diabetes.
    Kaufman DB, Rink JS
    Pediatr Transplant 2015 Jun; 19(4):345-7.
    [PubMed ID: 25940373]
    More Information
  • Helical tomotherapy-based total lymphoid irradiation: a more precise and less toxic radiation delivery system for consideration in composite tissue allotransplantation.
    Kempton SJ, Robertson FA, Bentz ML, Kaufman DB
    Plast. Reconstr. Surg. 2015 Mar; 135(3):655e-656e.
    [PubMed ID: 25647701]
    More Information
  • Diagnosis and Treatment of Pancreas Rejection.
    Redfield RR, Kaufman DB, Odorico JS
    Curr Transplant Rep 2015; 2(2):169-175.
    [PubMed ID: 26000231, PMC ID: 4431702]
    More Information
  • Conversion from calcineurin inhibitor-based immunosuppression to mammalian target of rapamycin inhibitors or belatacept in renal transplant recipients.
    Mulgaonkar S, Kaufman DB
    Clin Transplant 2014 Nov; 28(11):1209-24.
    [PubMed ID: 25142257]
    More Information
  • Application of Digital Image Analysis to Determine Pancreatic Islet Mass and Purity in Clinical Islet Isolation and Transplantation.
    Wang LJ, Kissler HJ, Wang X, Cochet O, Krzystyniak A, Misawa R, Golab K, Tibudan M, Grzanka J, Savari O, Kaufman DB, Millis M, Witkowski P
    Cell Transplant 2015; 24(7):1195-204.
    [PubMed ID: 24806436, PMC ID: 4436081]
    More Information Copyright © 2015 The Board of Regents of the University of Wisconsin System